Can a 13-Year-Old Take Toradol 10mg?
No, ketorolac (Toradol) is not FDA-approved for use in children under 17 years of age, and the 10mg oral formulation specifically should not be used in pediatric patients. 1
FDA Labeling and Age Restrictions
The FDA drug label explicitly states that "Ketorolac tromethamine tablets are not indicated for use in pediatric patients" and that "The safety and effectiveness of ketorolac tromethamine tablets in pediatric patients below the age of 17 have not been established." 1 Furthermore, the dosing table clearly indicates that for patients under age 17, "Oral not approved." 1
This represents a critical regulatory contraindication that supersedes other considerations. The oral formulation is only approved as continuation therapy following IV/IM administration in adults aged 17 and older.
Context from Pediatric Use in Hospital Settings
While the FDA labeling is definitive for oral ketorolac, it's important to understand the broader context:
Intravenous ketorolac has been used off-label in pediatric populations, including children as young as 6 months, primarily in postoperative settings. Recent pediatric cardiac surgery guidelines describe ketorolac as part of multimodal opioid-sparing regimens, though they emphasize significant safety concerns 2:
- Acute kidney injury risk, particularly in infants under 6 months, those with preexisting renal dysfunction, concomitant aspirin use, or single-ventricle palliation
- Increased bleeding risk requiring careful patient selection
- Use typically limited to 48 hours maximum in controlled hospital settings with monitoring
Recent research supports IV ketorolac safety in select pediatric surgical populations when appropriately dosed (typically 0.5 mg/kg every 6 hours) 3, 4, 5, 6, 7, but these studies involved intravenous administration in monitored hospital settings, not oral outpatient use.
Critical Distinctions
The question asks about oral Toradol 10mg in a 13-year-old, which presents multiple problems:
- Route of administration: Oral ketorolac is explicitly not approved for pediatric use 1
- Setting: Oral formulation implies outpatient use without the monitoring available in hospital settings
- Age: Patient is below the FDA-approved age threshold of 17 years
Common Pitfalls to Avoid
- Do not extrapolate from IV ketorolac studies in hospitalized children to justify oral use in outpatients
- Do not assume that off-label IV use in specialized settings translates to safety for oral formulations
- Do not confuse the limited evidence for short-term IV ketorolac in postoperative pediatric patients with approval for oral outpatient use
Alternative Approach
For a 13-year-old requiring analgesia, consider FDA-approved alternatives:
- Ibuprofen 10 mg/kg orally every 6-8 hours (maximum 40 mg/kg/day) 8
- Naproxen 5-7.5 mg/kg orally every 12 hours 8
- Acetaminophen 10-15 mg/kg orally every 6 hours (maximum 60 mg/kg/day) 8
These NSAIDs and acetaminophen have established pediatric dosing, safety profiles, and FDA approval for use in this age group.